Changes in Postmenopausal Hormone Replacement Therapy Use Among Women With High Cardiovascular Risk

Bibliographic Data

ID11024205
AuthorsAngela Hsu (All authors are with Columbia Presbyterian Medical Center, New York, NY.), Angela Ting‐Wei Hsu (0000-0002-5266-4947, NewYork–Presbyterian Hospital), Andrea Card (All authors are with Columbia Presbyterian Medical Center, New York, NY.), Susan Xiaoqin Lin (All authors are with Columbia Presbyterian Medical Center, New York, NY.), Susan Lin (0009-0007-3012-8063, NewYork–Presbyterian Hospital), Sean Mota (All authors are with Columbia Presbyterian Medical Center, New York, NY.), Olveen Carrasquillo (0000-0002-6524-7878, All authors are with Columbia Presbyterian Medical Center, New York, NY.), Andrew Moran (0000-0002-1825-0388, All authors are with Columbia Presbyterian Medical Center, New York, NY.), Andrew E Moran (0000-0003-3554-0085, NewYork–Presbyterian Hospital)
Year2009
Volume99
Issue12
Pages2184-2187
Publication date2009-12-01
Open AccessNo
TypeARTICLE
VenueAmerican Journal of Public Health (JOURNAL)
Journal identifiersISSN: 0090-0036 • E-ISSN: 1541-0048
PublisherAmerican Public Health Association (PUBLISHER • US)
DOI10.2105/ajph.2009.159889
PMID19833984
PMCIDPMC2775780
OpenAlexW2142879437
LanguageEN
References cited9

After randomized trials failed to support the use of hormone replacement therapy (HRT) for preventing cardiovascular disease (CVD), HRT use for postmenopausal women declined. Our analysis of 1999–2000 and 2003–2004 National Health and Nutrition Surveys (NHANES) shows that HRT use decreased 19% (from 27.6 to 8.4%; P

Breast cancer · Cancer · Estrogen replacement therapy · Gynecology · Hormone replacement therapy (female-to-male) · Hormone therapy · Menopause · Postmenopausal women · Randomized controlled trial · Estrogen and related hormone effects · Hormonal and reproductive studies · Internal Medicine · Medicine · Menopause: Health Impacts and Treatments